M

Mayinglong Pharmaceutical Group Co Ltd
SSE:600993

Watchlist Manager
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Watchlist
Price: 28.02 CNY -0.21% Market Closed
Market Cap: 12.1B CNY

Intrinsic Value

The intrinsic value of one Mayinglong Pharmaceutical Group Co Ltd stock under the Base Case scenario is 35.48 CNY. Compared to the current market price of 28.02 CNY, Mayinglong Pharmaceutical Group Co Ltd is Undervalued by 21%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
35.48 CNY
Undervaluation 21%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation History
Mayinglong Pharmaceutical Group Co Ltd

Valuation History Unavailable

Historical valuation for Mayinglong Pharmaceutical Group Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare Mayinglong Pharmaceutical Group Co Ltd to

Fundamental Analysis

Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
CN
Pharmaceuticals
Market Cap
12.1B CNY
IPO
May 17, 2004
CN
Pharmaceuticals
Market Cap
12.1B CNY
IPO
May 17, 2004
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Mayinglong Pharmaceutical Group Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Mayinglong Pharmaceutical Group Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mayinglong Pharmaceutical Group Co Ltd

Current Assets 4B
Cash & Short-Term Investments 3B
Receivables 501.1m
Other Current Assets 477.4m
Non-Current Assets 1.2B
Long-Term Investments 149m
PP&E 773.5m
Intangibles 225.4m
Other Non-Current Assets 59m
Efficiency

Free Cash Flow Analysis
Mayinglong Pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Mayinglong Pharmaceutical Group Co Ltd

Revenue
3.7B CNY
Cost of Revenue
-2B CNY
Gross Profit
1.7B CNY
Operating Expenses
-1.1B CNY
Operating Income
606.7m CNY
Other Expenses
-72.7m CNY
Net Income
534m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Mayinglong Pharmaceutical Group Co Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Positive Free Cash Flow
Exceptional ROIC
61/100
Profitability
Score

Mayinglong Pharmaceutical Group Co Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Mayinglong Pharmaceutical Group Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Mayinglong Pharmaceutical Group Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Mayinglong Pharmaceutical Group Co Ltd

Wall Street analysts forecast Mayinglong Pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Mayinglong Pharmaceutical Group Co Ltd is 38.63 CNY with a low forecast of 37.62 CNY and a high forecast of 40.43 CNY.

Lowest
Price Target
37.62 CNY
34% Upside
Average
Price Target
38.63 CNY
38% Upside
Highest
Price Target
40.43 CNY
44% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Mayinglong Pharmaceutical Group Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Mayinglong Pharmaceutical Group Co Ltd stock?

The intrinsic value of one Mayinglong Pharmaceutical Group Co Ltd stock under the Base Case scenario is 35.48 CNY.

Is Mayinglong Pharmaceutical Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 28.02 CNY, Mayinglong Pharmaceutical Group Co Ltd is Undervalued by 21%.

Back to Top